.
.
.
customize your news feed by choosing the topics that interest you.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
fda commissioner: it�s not a secret, sir. many experts know about it.
.